ICD-10 diagnosis code

L27.1 Localized skin eruption due to drugs and medicaments

This page in Swedish

L27.1 is the ICD-10 code for Localized skin eruption due to drugs and medicaments. It is a four-character subcategory of L27 (Dermatitis due to substances taken internally), the most specific level in the WHO edition. It belongs to the block L20–L30 (Dermatitis and eczema) in Chapter XII, Diseases of the skin and subcutaneous tissue.

Code type
Subcategory (4 characters)
Chapter
XII · L00–L99
Classification
WHO ICD-10, 2019 version

Coding notes

  • Use additional external cause code (Chapter XX), if desired, to identify drug.

L27.1 in national editions

Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.

NorwayICD-10-NO

L27.1Lokalisert hudreaksjon som skyldes legemiddel

DenmarkICD-10-DK

DL271Lokaliseret dermatitis forårsaget af indtaget lægemiddel

  • DL271AAutoimmun progesterondermatitis
  • DL271BDiuretikabetinget bulla
  • DL271CErythema fixum forårsaget af lægemiddel
GermanyICD-10-GM

L27.1Lokalisierte Hauteruption durch Drogen oder Arzneimittel

FranceICD-10-FR

L27.1Éruption localisée due à des médicaments

NetherlandsICD-10-NL

L27.1gelokaliseerde huideruptie door geneesmiddelen

United StatesICD-10-CM

L27.1Localized skin eruption due to drugs and medicaments taken internally

Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.

Look up another code

Stop looking codes up by hand

Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.

Try Docdemic free